Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2014, Article ID 452625, 13 pages
http://dx.doi.org/10.1155/2014/452625
Research Article

Computational Design of Apolipoprotein E4 Inhibitors for Alzheimer’s Disease Therapy from Traditional Chinese Medicine

Hung-Jin Huang,1 Hsin-Yi Chen,2 Cheng-Chun Lee,3 and Calvin Yu-Chian Chen2,3

1Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University, Taichung 40402, Taiwan
2Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan
3School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan

Received 14 February 2014; Revised 5 March 2014; Accepted 5 March 2014; Published 21 May 2014

Academic Editor: Chung Y. Hsu

Copyright © 2014 Hung-Jin Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Nussbaum and C. E. Ellis, “Alzheimer's disease and Parkinson's disease,” The New England Journal of Medicine, vol. 348, no. 14, pp. 1356–1364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Braak and E. Braak, “Staging of Alzheimer's disease-related neurofibrillary changes,” Neurobiology of Aging, vol. 16, no. 3, pp. 271–278, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Gomez-Isla, R. Hollister, H. West et al., “Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease,” Annals of Neurology, vol. 41, no. 1, pp. 17–24, 1997. View at Google Scholar
  4. J. Hardy, “Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal,” Journal of Alzheimer's Disease, vol. 9, supplement, no. 3, pp. 151–153, 2006. View at Google Scholar · View at Scopus
  5. S. Silhol, A. Calenda, V. Jallageas et al., “beta-Amyloid protein precursor in Microcebus murinus: genotyping and brain localization,” Neurobiology of Disease, vol. 3, no. 3, pp. 169–182, 1996. View at Google Scholar
  6. I. Dewachter, D. Reversé, N. Caluwaerts et al., “Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V7171] transgenic mice,” Journal of Neuroscience, vol. 22, no. 9, pp. 3445–3453, 2002. View at Google Scholar · View at Scopus
  7. M. M. Verbeek, I. Otte-Höller, J. A. M. Fransen, and R. M. W. de Waal, “Accumulation of the amyloid-β precursor protein in multivesicular body-like organelles,” Journal of Histochemistry and Cytochemistry, vol. 50, no. 5, pp. 681–690, 2002. View at Google Scholar · View at Scopus
  8. L. Torroja, H. Chu, I. Kotovsky, and K. White, “Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport,” Current Biology, vol. 9, no. 9, pp. 489–492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Bertram, M. B. McQueen, K. Mullin, D. Blacker, and R. E. Tanzi, “Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database,” Nature Genetics, vol. 39, no. 1, pp. 17–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Pericak-Vance, J. L. Bebout, P. C. Gaskell Jr. et al., “Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage,” The American Journal of Human Genetics, vol. 48, no. 6, pp. 1034–1050, 1991. View at Google Scholar · View at Scopus
  11. W. J. Strittmatter, A. M. Saunders, D. Schmechel et al., “Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 5, pp. 1977–1981, 1993. View at Google Scholar · View at Scopus
  12. L. A. Johnson, R. H. J. Olsen, L. S. Merkens et al., “Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner,” Neurobiology of Disease, vol. 64, pp. 150–162, 2014. View at Google Scholar
  13. A. D. Roses, “Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg,” Annals of the New York Academy of Sciences, vol. 855, pp. 738–743, 1998. View at Google Scholar · View at Scopus
  14. C. E. Finch, “Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, supplement 1, pp. 1718–1724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. W. Mahley and S. C. Rall Jr., “Apolipoprotein E: far more than a lipid transport protein,” Annual Review of Genomics and Human Genetics, vol. 1, no. 2000, pp. 507–537, 2000. View at Google Scholar · View at Scopus
  16. W. M. van der Flier, Y. A. Pijnenburg, N. C. Fox, and P. Scheltens, “Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ε4 allele,” The Lancet Neurology, vol. 10, no. 3, pp. 280–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Ungar, A. Altmann, and M. D. Greicius, “Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction,” Brain Imaging and Behavior, vol. 8, no. 2, pp. 262–273, 2014. View at Google Scholar
  18. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al., “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science, vol. 261, no. 5123, pp. 921–923, 1993. View at Google Scholar · View at Scopus
  19. L. A. Farrer, L. Cupples, J. L. Haines et al., “Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease: a meta-analysis,” JAMA: Journal of the American Medical Association, vol. 278, no. 16, pp. 1349–1356, 1997. View at Google Scholar
  20. C. Y. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Google Scholar
  21. H.-J. Huang, H. W. Yu, C.-Y. Chen et al., “Current developments of computer-aided drug design,” Journal of the Taiwan Institute of Chemical Engineers, vol. 41, no. 6, pp. 623–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. Huang, Y. R. Jian, and C. Y. Chen, “Traditional chinese medicine application in HIV: an in silico study,” Journal of Biomolecular Structure and Dynamics, vol. 32, no. 1, pp. 1–12, 2014. View at Google Scholar
  23. K.-W. Chang, T.-Y. Tsai, K.-C. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure and Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Google Scholar · View at Scopus
  24. S.-S. Chang, H.-J. Huang, and C. Y.-C. Chen, “High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan,” Molecular BioSystems, vol. 7, no. 12, pp. 3366–3374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T.-T. Chang, M.-F. Sun, H.-Y. Chen et al., “Screening from the world's largest TCM database against H1N1 virus,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 5, pp. 773–786, 2011. View at Google Scholar · View at Scopus
  26. C.-H. Lin, T.-T. Chang, M.-F. Sun et al., “Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 4, pp. 471–482, 2011. View at Google Scholar · View at Scopus
  27. Y. A. Tsou, K. C. Chen, H. C. Lin, S. S. Chang, and C. Y. Chen, “Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study,” PLoS ONE, vol. 7, no. 11, Article ID e50087, 2012. View at Google Scholar
  28. S.-C. Yang, S.-S. Chang, and C. Y.-C. Chen, “Identifying HER2 inhibitors from natural products database,” PLoS ONE, vol. 6, no. 12, Article ID e28793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-C. Yang, S.-S. Chang, H.-Y. Chen, and C. Y.-C. Chen, “Identification of potent EGFR inhibitors from TCM Database@Taiwan,” PLoS Computational Biology, vol. 7, no. 10, Article ID e1002189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-Y. Chen and C. Y.-C. Chen, “Insights into designing the dual-targeted HER2/HSP90 inhibitors,” Journal of Molecular Graphics and Modelling, vol. 29, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. W. I. Tou and C. Y. Chen, “In silico investigation of potential SRC kinase ligands from traditional Chinese medicine,” PLoS ONE, vol. 7, no. 3, Article ID e33728, 2012. View at Google Scholar
  32. H. Y. Chen, S. S. Chang, Y. C. Chan, and C. Y. Chen, “Discovery of novel insomnia leads from screening traditional Chinese medicine database,” Journal of Biomolecular Structure and Dynamics, vol. 32, no. 5, pp. 776–791, 2014. View at Google Scholar
  33. K.-C. Chen, K.-W. Chang, H.-Y. Chen, and C. Y.-C. Chen, “Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once?” Molecular BioSystems, vol. 7, no. 9, pp. 2711–2719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. C. Hung, S. S. Chang, P. C. Chang, C. C. Lee, and C. Y. Chen, “Memory enhancement by traditional Chinese medicine?” Journal of Biomolecular Structure and Dynamics, vol. 31, no. 12, pp. 1411–1439, 2013. View at Google Scholar
  35. T.-T. Chang, K.-C. Chen, K.-W. Chang et al., “In silico pharmacology suggests ginger extracts may reduce stroke risks,” Molecular BioSystems, vol. 7, no. 9, pp. 2702–2710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. C. Chen, Y. R. Jian, M. F. Sun et al., “Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine,” Journal of Biomolecular Structure and Dynamics, vol. 31, no. 11, pp. 1207–1218, 2013. View at Google Scholar
  37. K.-C. Chen and C. Yu-Chian Chen, “Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach,” Soft Matter, vol. 7, no. 8, pp. 4001–4008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. J. Huang, C. C. Lee, and C. Y. C. Chen, “Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 830490, 12 pages, 2014. View at Publisher · View at Google Scholar
  39. K. Y. Chen, S. S. Chang, and C. Y. Chen, “In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine,” PLoS ONE, vol. 7, no. 9, Article ID e43932, 2012. View at Google Scholar
  40. K. C. Chen, S. S. Chang, H. J. Huang et al., “Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine,” Journal of Biomolecular Structure and Dynamics, vol. 30, no. 6, pp. 662–683, 2012. View at Google Scholar
  41. K. C. Chen, S. S. Chang, F. J. Tsai, and C. Y. Chen, “Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?” Journal of Biomolecular Structure and Dynamics, vol. 31, no. 11, pp. 1219–1235, 2013. View at Google Scholar
  42. K.-C. Chen, M.-F. Sun, S.-C. Yang et al., “Investigation into potent inflammation inhibitors from traditional Chinese medicine,” Chemical Biology and Drug Design, vol. 78, no. 4, pp. 679–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Y.-C. Chen, “Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5,” Journal of Molecular Graphics and Modelling, vol. 28, no. 3, pp. 261–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. J. Huang and C. Y. Chen, “A possible solution for hairloss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine,” Journal of Biomolecular Structure and Dynamics, 2014. View at Publisher · View at Google Scholar
  45. Y. T. Chang, W. D. Lin, Z. N. Chin et al., “Nonketotic hyperglycinemia: a case report and brief review,” BioMedicine, vol. 2, no. 2, pp. 80–82, 2012. View at Google Scholar
  46. W. L. Liao and F. J. Tsai, “Personalized medicine: a paradigm shift in healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013. View at Google Scholar
  47. D. Y. Lin, F. J. Tsai, C. H. Tsai, and C. Y. Huang, “Mechanisms governing the protective effect of 17beta-estradiol and estrogen receptors against cardiomyocyte injury,” BioMedicine, vol. 1, no. 1, pp. 21–28, 2011. View at Google Scholar
  48. F. J. Tsai, “Rare diseases: a mysterious puzzle,” BioMedicine, vol. 3, no. 2, pp. 65–104, 2013. View at Google Scholar
  49. C. H. Wang, W. D. Lin, and F. J. Tsai, “Craniofacial dysmorphism, what is your diagnosis?” BioMedicine, vol. 2, no. 2, pp. 49–50, 2012. View at Google Scholar
  50. I. C. Chou, W. D. Lin, C. H. Wang et al., “Möbius syndrome in a male with XX/XY mosaicism,” BioMedicine, vol. 3, no. 2, pp. 102–104, 2013. View at Google Scholar
  51. I. C. Chou, W. D. Lin, C. H. Wang et al., “Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children,” BioMedicine, vol. 3, no. 2, pp. 88–91, 2013. View at Google Scholar
  52. W. Y. Lin, H. P. Liu, J. S. Chang et al., “Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation,” BioMedicine, vol. 3, no. 2, pp. 73–81, 2013. View at Google Scholar
  53. C. H. Wang, W. D. Lin, D. T. Bau et al., “Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway,” BioMedicine, vol. 3, no. 2, pp. 82–87, 2013. View at Google Scholar
  54. T.-Y. Tsai, K.-W. Chang, and C. Y.-C. Chen, “IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Y.-C. Chen, “Weighted equation and rules: a novel concept for evaluating protein-ligand interaction,” Journal of Biomolecular Structure and Dynamics, vol. 27, no. 3, pp. 271–282, 2009. View at Google Scholar · View at Scopus
  56. C. C. Lee, C. H. Tsai, L. Wan et al., “Increased incidence of Parkinsonism among Chinese with beta-glucosidase mutation in central Taiwan,” BioMedicine, vol. 3, no. 2, pp. 92–94, 2013. View at Google Scholar
  57. C. Y.-C. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. Accelerys, Discovery Studio Client V2. 5, Accelrys, San Diego, Calif, USA, 2009.
  59. B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically disordered amino acids,” Biochimica et Biophysica Acta: Proteins and Proteomics, vol. 1804, no. 4, pp. 996–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. D. J. Diller and K. M. Merz Jr., “High throughput docking for library design and library prioritization,” Proteins, vol. 43, no. 2, pp. 113–124, 2001. View at Google Scholar
  61. A. C. Wallace, R. A. Laskowski, and J. M. Thornton, “LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions,” Protein Engineering, vol. 8, no. 2, pp. 127–134, 1995. View at Google Scholar · View at Scopus
  62. R. A. Laskowski and M. B. Swindells, “LigPlot+: multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling, vol. 51, no. 10, pp. 2778–2786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Pronk, S. Pall, R. Schulz et al., “GROMACS 4. 5: a high-throughput and highly parallel open source molecular simulation toolkit,” Bioinformatics, vol. 29, no. 7, pp. 845–854, 2013. View at Google Scholar
  64. J. E. Jones, “On the determination of molecular fields. II. From the equation of state of a gas,” Proceedings of the Royal Society of London A, vol. 106, no. 738, pp. 463–477, 1924. View at Google Scholar
  65. J. Tersoff, “Modeling solid-state chemistry: interatomic potentials for multicomponent systems,” Physical Review B, vol. 39, no. 8, pp. 5566–5568, 1989. View at Publisher · View at Google Scholar · View at Scopus
  66. M. S. Daw, S. M. Foiles, and M. I. Baskes, “The embedded-atom method: a review of theory and applications,” Materials Science Reports, vol. 9, no. 7-8, pp. 251–310, 1993. View at Google Scholar · View at Scopus
  67. F. Cleri and V. Rosato, “Tight-binding potentials for transition metals and alloys,” Physical Review B, vol. 48, no. 1, pp. 22–33, 1993. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Y. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Google Scholar
  69. W. I. Tou, S. S. Chang, C. C. Lee, and C. Y. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, article 844, 2013. View at Google Scholar
  70. W. I. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, vol. 19, no. 4, pp. 367–372, 2014. View at Google Scholar
  71. E. Chovancova, A. Pavelka, P. Benes et al., “CAVER 3. 0: a tool for the analysis of transport pathways in dynamic protein structures,” PLoS Computational Biology, vol. 8, no. 10, Article ID e1002708, 2012. View at Google Scholar